Experts
Pharmaxis (ASX: PXS) has changed its name to Syntara - SNT (ASX: SNT).
Below are the previous articles from Pharmaxis (ASX: PXS):
RELATED STOCKHEAD STORIES
Health & Biotech
This ASX stock is watching you while you sleep… because it could point to Parkinson’s disease
Experts
ScoPo’s Powerplays: ASX health stocks finish reporting season in pretty strong shape
Health & Biotech
ASX Health Stocks: Pharmaxis gets $5m to fund groundbreaking collaboration study of lead drug PXS‐4728
News
Market Highlights: Euro inflation hits record high and 5 ASX small caps to watch on Thursday
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
Experts
ScoPo’s Powerplays: Which ASX health stocks are winners from the Federal Budget?
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Health & Biotech
ScoPo’s Powerplays: Investors look to Healthcare for ESG exposure, and Volpara is the poster child
Health & Biotech
ASX Health Stocks: Amplia eyes human trials for pancreatic cancer drug
News
Closing Bell: ASX edges lower, but hydrogen stocks rip higher
News
ASX Small Cap Lunch Wrap: Who’s up for a new ETF today?
Health & Biotech
ASX Health Stocks: Pharmaxis jumps 9pc on FDA approval
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
Health & Biotech
ASX Health Stocks: Pharmaxis progresses to Phase 2 study on bone marrow cancer
Health & Biotech
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
Health & Biotech
ASX Health Stocks: Beamtree gets on the M&A trail while Creso Pharma eyes NASDAQ listing
Health & Biotech
